Publications of Lutz W. Kracht
All genres
Journal Article (57)
2010
Journal Article
37 (1), pp. 84 - 92 (2010)
Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. European Journal of Nuclear Medicine and Molecular Imaging
Journal Article
133 (7), pp. 1994 - 2006 (2010)
Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain 2009
Journal Article
50 (12), pp. 1962 - 1968 (2009)
Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine
Journal Article
93 (3), pp. 425 - 430 (2009)
Imaging biological activity of a glioblastoma treated with an individual patient-tailored, experimental therapy regimen. Journal of Neuro-Oncology
Journal Article
36 (12), pp. 1960 - 1967 (2009)
Non-invasive quantification of 18F-FLT human brain PET for the assessment of tumour proliferation in patients with high grade glioma. European Journal of Nuclear Medicine and Molecular Imaging 2008
Journal Article
33 (12), pp. 922 - 924 (2008)
Perrault Syndrome with progressive nervous system involvement. Clinical Nuclear Medicine
Journal Article
71 (10), pp. 708 - 713 (2008)
STN-DBS activates the target area in Parkinson disease. An FDG-PET study. Neurology
Journal Article
47 (2), pp. 73 - 79 (2008)
Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging. Nuklearmedizin-Nuclear Medicine
Journal Article
44 (1), pp. 29 - 45 (2008)
Functional retrograde amnesia: a multiple case study. Cortex
Journal Article
65 (3), pp. 407 - 411 (2008)
Altered cerebral glucose metabolism in a family with clinical features resembling mitochondrial neurogastrointestinal encephalomyopathy syndrome in association with multiple mitochondrial DNA deletions. Archives of Neurology
Journal Article
14 (7), pp. 2049 - 2055 (2008)
Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Clinical Cancer Research
Journal Article
28 (4), pp. 484 - 494 (2008)
Neuroimaging in patients with gliomas. Seminars in Neurology 2007
Journal Article
51 (2), pp. 164 - 181 (2007)
Role of in vivo imaging of the central nervous system for developing novel drugs. Quarterly Journal of Nuclear Medicine and Molecular Imaging
Journal Article
51 (2), pp. 164 - 181 (2007)
Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2006
Journal Article
33 (5), pp. 516 - 524 (2006)
Use of C-11-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging
Journal Article
26 (9), pp. 1122 - 1127 (2006)
Direct demonstration of transcallosal disinhibition in language networks. Journal of Cerebral Blood Flow and Metabolism 2005
Journal Article
46 (12), pp. 1948 - 1958 (2005)
F-18-fluoro-L-thymidine and C-11-methylmethionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine
Journal Article
139 (2), pp. 115 - 126 (2005)
Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Research-Neuroimaging
Journal Article
36 (2), p. 440 - 440 (2005)
Severity of ischemia determines space-occupying brain edema after middle cerebral artery infarction. Stroke
Journal Article
2 (2), pp. 333 - 347 (2005)
Imaging in neurooncology. NeuroRx